Atlas Trials

Combination of Netupitant and Palonosetron (Akynzeo®) in the Treatment of Refractory CINV

Clinical trial NCT03008213 · TERMINATED

Trial details

NCT number
NCT03008213
Sponsor
Joseph Ma
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Chemotherapy Induced Nausea Vomiting
Start date
2017-01-01
Primary completion
2018-01-22
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.